Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
130-nm albumin-bound paclitaxel
×
1 year
×
Clear all
Filters
3
NCT06312176
2026-03-13
MK-2870-010
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,200 enrolled
NCT06841354
2026-03-13
TroFuse-011
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,000 enrolled
NCT04895358
2026-03-11
KEYNOTE-B49
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
340 enrolled
NCT05017012
2026-01-08
MK-3475A-C18
Merck Sharp & Dohme LLC
Phase 1
Active not recruiting
72 enrolled